124 related articles for article (PubMed ID: 38857551)
1. Physiologically based kinetic (PBK) modeling of propiconazole using a machine learning-enhanced read-across approach for interspecies extrapolation.
Wu Y; Sinclair G; Avanasi R; Pecquet A
Environ Int; 2024 Jul; 189():108804. PubMed ID: 38857551
[TBL] [Abstract][Full Text] [Related]
2. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.
Najjar A; Punt A; Wambaugh J; Paini A; Ellison C; Fragki S; Bianchi E; Zhang F; Westerhout J; Mueller D; Li H; Shi Q; Gant TW; Botham P; Bars R; Piersma A; van Ravenzwaay B; Kramer NI
Arch Toxicol; 2022 Dec; 96(12):3407-3419. PubMed ID: 36063173
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
[TBL] [Abstract][Full Text] [Related]
4. Unexpected Effects of Propiconazole, Tebuconazole, and Their Mixture on the Receptors CAR and PXR in Human Liver Cells.
Knebel C; Neeb J; Zahn E; Schmidt F; Carazo A; Holas O; Pavek P; Püschel GP; Zanger UM; Süssmuth R; Lampen A; Marx-Stoelting P; Braeuning A
Toxicol Sci; 2018 May; 163(1):170-181. PubMed ID: 29420809
[TBL] [Abstract][Full Text] [Related]
5. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
[TBL] [Abstract][Full Text] [Related]
6. Use of physiologically based kinetic modeling-facilitated reverse dosimetry of in vitro toxicity data for prediction of in vivo developmental toxicity of tebuconazole in rats.
Li H; Zhang M; Vervoort J; Rietjens IM; van Ravenzwaay B; Louisse J
Toxicol Lett; 2017 Jan; 266():85-93. PubMed ID: 27890808
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity assessment of triazole fungicides on mitochondrial oxidative respiration and lipids in differentiated human SH-SY5Y neuroblastoma cells.
Sanchez CL; Souders CL; Pena-Delgado CJ; Nguyen KT; Kroyter N; Ahmadie NE; Aristizabal-Henao JJ; Bowden JA; Martyniuk CJ
Neurotoxicology; 2020 Sep; 80():76-86. PubMed ID: 32585290
[TBL] [Abstract][Full Text] [Related]
8. Pregnane X receptor mediates steatotic effects of propiconazole and tebuconazole in human liver cell lines.
Knebel C; Buhrke T; Süssmuth R; Lampen A; Marx-Stoelting P; Braeuning A
Arch Toxicol; 2019 May; 93(5):1311-1322. PubMed ID: 30989312
[TBL] [Abstract][Full Text] [Related]
9. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
[TBL] [Abstract][Full Text] [Related]
10. Residues and dissipation kinetics of triazole fungicides difenoconazole and propiconazole in wheat and soil in Chinese fields.
Zhang Z; Jiang W; Jian Q; Song W; Zheng Z; Wang D; Liu X
Food Chem; 2015 Feb; 168():396-403. PubMed ID: 25172726
[TBL] [Abstract][Full Text] [Related]
11. Toxicity profiles in mice treated with hepatotumorigenic and non-hepatotumorigenic triazole conazole fungicides: Propiconazole, triadimefon, and myclobutanil.
Allen JW; Wolf DC; George MH; Hester SD; Sun G; Thai SF; Delker DA; Moore T; Jones C; Nelson G; Roop BC; Leavitt S; Winkfield E; Ward WO; Nesnow S
Toxicol Pathol; 2006; 34(7):853-62. PubMed ID: 17178687
[TBL] [Abstract][Full Text] [Related]
12. Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action.
Currie RA; Peffer RC; Goetz AK; Omiecinski CJ; Goodman JI
Toxicology; 2014 Jul; 321():80-8. PubMed ID: 24675475
[TBL] [Abstract][Full Text] [Related]
13. Increased triazole-resistance and cyp51A mutations in Aspergillus fumigatus after selection with a combination of the triazole fungicides difenoconazole and propiconazole.
Wang F; Yao S; Cao D; Ju C; Yu S; Xu S; Fang H; Yu Y
J Hazard Mater; 2020 Dec; 400():123200. PubMed ID: 32593937
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
Ellison CA
Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
[TBL] [Abstract][Full Text] [Related]
15. A generic avian physiologically-based kinetic (PBK) model and its application in three bird species.
Baier V; Paini A; Schaller S; Scanes CG; Bone AJ; Ebeling M; Preuss TG; Witt J; Heckmann D
Environ Int; 2022 Nov; 169():107547. PubMed ID: 36179644
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of Published Physiologically-based Kinetic Models and an Assessment of their Chemical Space Coverage.
Thompson CV; Firman JW; Goldsmith MR; Grulke CM; Tan YM; Paini A; Penson PE; Sayre RR; Webb S; Madden JC
Altern Lab Anim; 2021 Sep; 49(5):197-208. PubMed ID: 34836462
[TBL] [Abstract][Full Text] [Related]
17. Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification.
Chou WC; Lin Z
Environ Int; 2019 Aug; 129():408-422. PubMed ID: 31152982
[TBL] [Abstract][Full Text] [Related]
18. Integrating in vitro data and physiologically based kinetic modeling-facilitated reverse dosimetry to predict human cardiotoxicity of methadone.
Shi M; Bouwmeester H; Rietjens IMCM; Strikwold M
Arch Toxicol; 2020 Aug; 94(8):2809-2827. PubMed ID: 32367273
[TBL] [Abstract][Full Text] [Related]
19. PBK modelling of topical application and characterisation of the uncertainty of C
Li H; Reynolds J; Sorrell I; Sheffield D; Pendlington R; Cubberley R; Nicol B
Toxicol Appl Pharmacol; 2022 May; 442():115992. PubMed ID: 35346730
[TBL] [Abstract][Full Text] [Related]
20. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
